Social Media Ideas for Bioix

Cytomos’ AuraCyt Digital Predictive Cell Analytics Platform Showcased at BIO Conference

Cytomos says its benchtop cell analytics intelligence system combines the compact Celledonia analyzer with the sensors of the AuraCyt modules to transform complex cellular data int...

ImmunityBio: Could Be One Approval Away From A Multi-Billion Dollar Breakout

Baron Opportunity Fund Q1 2026 Shareholder Letter

INVIVYD

INVIVYD Anonymous (not verified) Thu, 07/02/2026 - 06:06 field_thread_url https://cafepharma.com/boards/threads/invivyd.703943/ board na...

<![CDATA[The Only AI Simulation Built for Life Sciences ]]>

<![CDATA[Solving Data Problems with Casual Human Biology: Q&A with Dr. Brent Richards]]>

MGI Tech and Shanghai AI Laboratory Unveil ProtoPilot and BioLab Bench, Pioneering Physical AI for Life Sciences

SHENZHEN, China, July 5, 2026 /PRNewswire/ -- MGI's subsidiary, Genoria AI, in collaboration with the Shanghai Artificial Intelligence Laboratory, today announced the launch of two...

MPI Approval and IXOM Partnership Signal Growing Momentum for Continuous Pathogen Control for New Zealand's Food Industr...

As Food Safety Expectations Continue to Evolve, Synexis® LLC and IXOM are Helping Food and Dairy Processors Explore New Approaches to Indoor Pathogen Control

The State of Biologics Testing Report 2026

This report is intended to inform discussion and decision making, not to prescribe solutions. Produced in collaboration with GEN, it reflects the collective voice of an industry ad...

BridgeBio

BridgeBio Anonymous (not verified) Thu, 07/09/2026 - 09:10 field_thread_url https://cafepharma.com/boards/threads/bridgebio.698762/ boar...

Next Generation Biopharma Innovation

In a quest to provide more relevant translational data, traditional in vivo models join forces with new approach methodologies. The post Next Generation Biopharma Innovation appear...

Oxford Biomedica plc (OXBDF) Analyst/Investor Day - Slideshow

<![CDATA[Nuvation Bio’s Global Strategy]]>

Iovance

Iovance Anonymous (not verified) Sat, 06/13/2026 - 20:53 field_thread_url https://cafepharma.com/boards/threads/iovance.666981/ board na...

BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Bi...

BioRestorative Therapies, Inc. today announced the successful completion of manufacturing for its BRTX-100 Phase 2 clinical trial.

<![CDATA[Transitioning from BGB to BGBx: Q&A with David Coman]]>

BioAge Labs, Inc. (BIOA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

FACTOR X Emerges from Stealth with Novel RNA - based Technology to Transform the Global Beauty Industry

FACTOR X is a newly launched longevity-focused beauty technology company developing a breakthrough cellular delivery platform designed to transform the anti-aging skincare industry...

Ipca inks licensing agreement with Bhami Research for biologics delivery platform access

Licencing agreement grants Ipca access to Bhami Research’s proprietary high-concentration subcutaneous biologics delivery platform for the development and commercialisation of mult...

Bio-Techne, Refeyn Partner on Workflow for Bispecific Antibody, Biosimilar Characterization

The workflow pairs Bio-Techne’s MauriceFlex imaged capillary isoelectric focusing fractionation system with Refeyn's TwoMP mass photometry platform to connect charge heterogeneity...